Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W D Zollinger

Showing results (51-60 of 56) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 56 results.
Proceedings of the National Academy of Sciences of the United States of America|July 1, 1986
Intercontinental spread of a genetically distinctive complex of clones of Neisseria meningitidis causing epidemic diseaseD A Caugant, L O Frøholm, K Bøvre, et al.
Antonie Van Leeuwenhoek|January 1, 1987
Intercontinental spread of Neisseria meningitidis clones of the ET-5 complexD A Caugant, L O Frøholm, K Bøvre, et al.
Molecular Microbiology|June 1, 1996
Capsule phase variation in Neisseria meningitidis serogroup B by slipped-strand mispairing in the polysialyltransferase gene (siaD): correlation with bacterial invasion and the outbreak of meningococcal diseaseS Hammerschmidt, A Müller, H Sillmann, et al.
The Journal of Infectious Diseases|May 1, 1996
A noncovalent complex vaccine prepared with detoxified Escherichia coli J5 (Rc chemotype) lipopolysaccharide and Neisseria meningitidis Group B outer membrane protein produces protective antibodies against gram-negative bacteremiaA K Bhattacharjee, S M Opal, R Taylor, et al.
Infection and Immunity|December 1, 1996
Outer membrane protein of Neisseria meningitidis as a mucosal adjuvant for lipopolysaccharide of Brucella melitensis in mouse and guinea pig intranasal immunization modelsL L Van De Verg, A B Hartman, A K Bhattacharjee, et al.
Vaccine|January 5, 2011
A phase 1 study of a meningococcal native outer membrane vesicle vaccine made from a group B strain with deleted lpxL1 and synX, over-expressed factor H binding protein, two PorAs and stabilized OpcA expressionP B Keiser, S Biggs-Cicatelli, E E Moran, et al.
Pageof 6

Showing results (51-60 of 56) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 56 results.
Proceedings of the National Academy of Sciences of the United States of America|July 1, 1986
Intercontinental spread of a genetically distinctive complex of clones of Neisseria meningitidis causing epidemic diseaseD A Caugant, L O Frøholm, K Bøvre, et al.
Antonie Van Leeuwenhoek|January 1, 1987
Intercontinental spread of Neisseria meningitidis clones of the ET-5 complexD A Caugant, L O Frøholm, K Bøvre, et al.
Molecular Microbiology|June 1, 1996
Capsule phase variation in Neisseria meningitidis serogroup B by slipped-strand mispairing in the polysialyltransferase gene (siaD): correlation with bacterial invasion and the outbreak of meningococcal diseaseS Hammerschmidt, A Müller, H Sillmann, et al.
The Journal of Infectious Diseases|May 1, 1996
A noncovalent complex vaccine prepared with detoxified Escherichia coli J5 (Rc chemotype) lipopolysaccharide and Neisseria meningitidis Group B outer membrane protein produces protective antibodies against gram-negative bacteremiaA K Bhattacharjee, S M Opal, R Taylor, et al.
Infection and Immunity|December 1, 1996
Outer membrane protein of Neisseria meningitidis as a mucosal adjuvant for lipopolysaccharide of Brucella melitensis in mouse and guinea pig intranasal immunization modelsL L Van De Verg, A B Hartman, A K Bhattacharjee, et al.
Vaccine|January 5, 2011
A phase 1 study of a meningococcal native outer membrane vesicle vaccine made from a group B strain with deleted lpxL1 and synX, over-expressed factor H binding protein, two PorAs and stabilized OpcA expressionP B Keiser, S Biggs-Cicatelli, E E Moran, et al.
Pageof 6